These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 26311052)

  • 21. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
    Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
    Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis.
    Chang SM; Hu WW
    J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205.
    Yang W; Hong L; Xu X; Wang Q; Huang J; Jiang L
    Tumour Biol; 2017 Jul; 39(7):1010428317711315. PubMed ID: 28671039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis.
    Yuan W; Xiaoyun H; Haifeng Q; Jing L; Weixu H; Ruofan D; Jinjin Y; Zongji S
    Int J Med Sci; 2014; 11(7):691-6. PubMed ID: 24843318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
    Zuo Y; Li Y; Zhou Z; Ma M; Fu K
    Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development.
    Jin C; Yan B; Lu Q; Lin Y; Ma L
    Tumour Biol; 2016 Jun; 37(6):7383-94. PubMed ID: 26676637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of genetic variation in the lncRNA HOTAIR associated with HPV16-related cervical cancer pathogenesis.
    Sharma Saha S; Roy Chowdhury R; Mondal NR; Chakravarty B; Chatterjee T; Roy S; Sengupta S
    Cell Oncol (Dordr); 2016 Dec; 39(6):559-572. PubMed ID: 27683269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The involvement of MALAT1-ALKBH5 signaling axis into proliferation and metastasis of human papillomavirus-positive cervical cancer.
    Wu S; Liu L; Xu H; Zhu Q; Tan M
    Cancer Biol Ther; 2023 Dec; 24(1):2249174. PubMed ID: 37639643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulated MALAT1 relates to recurrent pregnancy loss via sponging miRNAs.
    Wang Y; Liu HZ; Liu Y; Wang HJ; Pang WW; Zhang JJ
    Kaohsiung J Med Sci; 2018 Sep; 34(9):503-510. PubMed ID: 30173780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA Malat1 promotes gallbladder cancer development by acting as a molecular sponge to regulate miR-206.
    Wang SH; Zhang WJ; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
    Oncotarget; 2016 Jun; 7(25):37857-37867. PubMed ID: 27191262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of long non-coding RNA MALAT1 increases the blood-tumor barrier permeability by up-regulating miR-140.
    Ma J; Wang P; Yao Y; Liu Y; Li Z; Liu X; Li Z; Zhao X; Xi Z; Teng H; Liu J; Xue Y
    Biochim Biophys Acta; 2016 Feb; 1859(2):324-38. PubMed ID: 26619802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.
    Luan W; Li L; Shi Y; Bu X; Xia Y; Wang J; Djangmah HS; Liu X; You Y; Xu B
    Oncotarget; 2016 Sep; 7(39):63901-63912. PubMed ID: 27564100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
    Geng D; Song X; Ning F; Song Q; Yin H
    Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of lncRNA MALAT1 attenuates acute myocardial infarction through miR-320-Pten axis.
    Hu H; Wu J; Li D; Zhou J; Yu H; Ma L
    Biomed Pharmacother; 2018 Oct; 106():738-746. PubMed ID: 29990866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non‑coding nuclear paraspeckle assembly transcript 1 acts as prognosis biomarker and increases cell growth and invasion in cervical cancer by sequestering microRNA‑101.
    Wang L; Zhu H
    Mol Med Rep; 2018 Feb; 17(2):2771-2777. PubMed ID: 29207151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion.
    Yang L; Bai HS; Deng Y; Fan L
    Eur Rev Med Pharmacol Sci; 2015 Sep; 19(17):3187-93. PubMed ID: 26400521
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Chuang PC; Chen PT; Wang CC; Su WH; Chen YH; Huang EY
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA LINC00958 regulates cell sensitivity to radiotherapy through RRM2 by binding to microRNA-5095 in cervical cancer.
    Zhao H; Zheng GH; Li GC; Xin L; Wang YS; Chen Y; Zheng XM
    J Cell Physiol; 2019 Dec; 234(12):23349-23359. PubMed ID: 31169309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MALAT1 Promotes Cell Apoptosis and Suppresses Cell Proliferation in Testicular Ischemia-Reperfusion Injury by Sponging MiR-214 to Modulate TRPV4 Expression.
    Li W; Ning JZ; Cheng F; Yu WM; Rao T; Ruan Y; Yuan R; Zhang XB; Du Y; Xiao CC
    Cell Physiol Biochem; 2018; 46(2):802-814. PubMed ID: 29870987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.